CALL FOR SPEAKERS
Join us as we deliver a spark to the roll-out of customised solutions that change how healthcare is delivered.
SHOWCASE YOUR EXPERTISE AND JOIN THE DEBATE
Share your expertise and vision with the most influential healthcare professionals and government bodies.
Speaking at PrecisionMed Summit will give you a chance to position yourself as an industry thought-leader and gain new allies to grow business opportunities for your organisation.
- Gain visibility throughout the medical community.
- Drive change with your insights and knowledge
- Influence industry professionals and build credibility
- Expand your professional network to build your business
SUBMIT YOUR INTEREST BELOW:
Previous Speakers
Dame Professor Sue Hill
Chief Scientific Officer, England
Exclusive Pre-recorded Session
Min S. Park, PhD
CSO, Sanimed International, Abu Dhabi
H.E Dr. Maryam Matar
Founder and Chairperson, UAE Genetic Diseases Association (UAEGDA)
Robert C. Green, MD, MPH
Professor of Medicine, Harvard Medical School, Geneticist, Mass General Brigham, Broad Institute; Director, Genomes2People Research Program
Ahmad Abou Tayoun, PhD, FACMG
Director, Genomics Center at Al Jalila Children’s; Associate
Professor of Genetics, Mohammed Bin Rashid University of Medicine and Health Sciences
Heidi Rehm, PhD
Chief Genomics Officer, Department of Medicine, MGH; Co-Director, Medical and Population Genetics, Broad Institute
Exclusive Pre-recorded Session
Joanne Hackett
Head of Genomic and Precision Medicine, IQVIA
Renyan Lou
Head of Genomic and Precision Medicine, IQVIA
Dr Fatma Alhashimi, PhD
Director of Sheikh Zayed Genetic Research Centre
Khalid Fakhro, PhD
Chief Research Officer,
Sidra Medicine
Fatma Al Jasmi, MBBS, FRCPC, FCCMG
Chair of Genetic & Genomic Department, College of Medicine & Health Science, UAE University
Dr Marjane Le Bagousse, MD, MSc, EM
Medical Director,
Veracyte Immuno-Oncology
Dr Younes Mokrab
Principal investigator, Head of Medical and Population Genomics Lab, Sidra Medicine
Hinda Daggag, PhD
Corporate Head of Genetic Projects, SEHA
Aaron Han, MD, PhD
Consultant, Pathology, COVID Lab, Infection Control, King’s College Hospital London – UAE
Lova Satyanarayana Matsa, PhD
Scientific Director, Igenomix
Sarah Chahine
Emerging Markets Leader for Clinical Sequencing Division, Thermo Fisher Scientific
Shoaib Al Zadjali, PhD
Head of Research Laboratories, Sultan Qaboos Comprehensive Cancer Care & Research Centre (SQCCCRC)
Dr. Ihsan Almarzooqi
Co-Founder & Managing Director, Glucare
Byoungkwon Kim M.D.
Consultant pathologist in Department of Pathology, Sheikh Khalifa Specialty Hospital (SKSH), United Arab Emirates
Dr Susanna Akiki, PhD DipRCPath (UK)
Consultant Clinical Scientist, Head of Haemato Oncology, Diagnostic Genomic Division, Hamad Medical Corporation, Qatar
Dr. Shakir Bahzad, MD, FRCPC
Head of Molecular Pathology Lab, Kuwait Cancer Control Center
Dr Bernice Lo
Principal Investigator, Precision Medicine Research Branch, Sidra Medicine
Abdul Wahid Khan
BIS Research
George P. Patrinos
Professor, University of Patras, Greece; Adjunct Professor; United Arab Emirates University, Department of Genetics and Genomics Al-Ain, UAE
Dr. Samih Alqawlaq
Senior Clinical Sales Specialist, Illumina
Mohamed Nagy, Pharm, RPh, MS
Head of Personalized Medication Management Unit, Children’s Cancer Hospital, Egypt
Stefan Nierkens, PhD
Associate Professor and Medical Immunologist, Center for Translational Immunology, University Medica Center Utrecht
Richard O Kennedy,
B.Sc., Ph.D., C. Biol., FRSB., F.I.Biol.I., Dip. F.S., Dip. C.S., Dip. Computing, MRIA
Vice-President for Research, Hamad Bin Khalifa University; and Vice-President for Research, Development and Innovation (RDI), Qatar Foundation
Shameer Khader, PhD
Senior Director (Machine Learning Research)
Dr. Stefan Griesbach
Head of Sales,
CeGaT GmbH
Toby Huang, BSc, MSc
BD Director, APAC & ME
MGI Tech Co Ltd
Ayman El-Hattab, MD
Consultant & Scientific Advisory Board member for Middle East, Igenomix
Houari Abdesselem, PhD
Manager, Proteomics Core Facility, Qatar Biomedical Research Institute, Hamad Bin Khalifa University
José Luis Costa
Global Director of Scientific Affairs of the Clinical NGS and Oncology Division,
Thermo Fisher Scientific
Peeter Padrik, MD, PhD
Founder and CEO of Antegenes; Associate Professor of Oncology at University of Tartu, Estonia; Medical Oncologist, Tartu University Hospital, Estonia
M. Walid Qoronfleh, PhD, MBA
Executive Director, Q3CG Research Institute (QRI)
The estimated precision medicine market valuation by the year 2025 is about USD 126.14 billion. The compound annual growth rate of the market is predicted to be 12.48% during the forecast period (2017-2025).
*Source: Market Research Future
